CN102161960B - 一种美容调节酒 - Google Patents
一种美容调节酒 Download PDFInfo
- Publication number
- CN102161960B CN102161960B CN2011100094185A CN201110009418A CN102161960B CN 102161960 B CN102161960 B CN 102161960B CN 2011100094185 A CN2011100094185 A CN 2011100094185A CN 201110009418 A CN201110009418 A CN 201110009418A CN 102161960 B CN102161960 B CN 102161960B
- Authority
- CN
- China
- Prior art keywords
- radix
- time
- root
- wine
- filtering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000001105 regulatory effect Effects 0.000 title claims abstract description 19
- 239000009636 Huang Qi Substances 0.000 claims abstract description 23
- 239000003814 drug Substances 0.000 claims abstract description 20
- 241000219099 Parthenocissus quinquefolia Species 0.000 claims abstract description 19
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 claims abstract description 19
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 16
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 16
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 15
- 235000003392 Curcuma domestica Nutrition 0.000 claims abstract description 15
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 15
- 235000013976 turmeric Nutrition 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 235000012054 meals Nutrition 0.000 claims abstract description 5
- 230000003796 beauty Effects 0.000 claims description 25
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 20
- 238000001914 filtration Methods 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 18
- 210000000582 semen Anatomy 0.000 claims description 16
- 239000012530 fluid Substances 0.000 claims description 15
- 238000007598 dipping method Methods 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 6
- 235000020072 grain neutral spirit Nutrition 0.000 claims description 5
- 240000002045 Guettarda speciosa Species 0.000 claims 3
- 210000004369 blood Anatomy 0.000 abstract description 24
- 239000008280 blood Substances 0.000 abstract description 24
- 230000000694 effects Effects 0.000 abstract description 20
- 230000036541 health Effects 0.000 abstract description 7
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 230000035622 drinking Effects 0.000 abstract description 6
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 4
- 230000004060 metabolic process Effects 0.000 abstract description 4
- 241000213006 Angelica dahurica Species 0.000 abstract description 3
- 230000001965 increasing effect Effects 0.000 abstract description 3
- 241001061264 Astragalus Species 0.000 abstract description 2
- 244000170916 Paeonia officinalis Species 0.000 abstract description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract description 2
- 230000036528 appetite Effects 0.000 abstract description 2
- 235000019789 appetite Nutrition 0.000 abstract description 2
- 210000001367 artery Anatomy 0.000 abstract description 2
- 235000006533 astragalus Nutrition 0.000 abstract description 2
- 230000008021 deposition Effects 0.000 abstract description 2
- 230000029087 digestion Effects 0.000 abstract description 2
- 239000002932 luster Substances 0.000 abstract description 2
- 210000004233 talus Anatomy 0.000 abstract description 2
- 238000010792 warming Methods 0.000 abstract description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 206010014970 Ephelides Diseases 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 102000015779 HDL Lipoproteins Human genes 0.000 abstract 1
- 108010010234 HDL Lipoproteins Proteins 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 208000003351 Melanosis Diseases 0.000 abstract 1
- 241001180876 Saposhnikovia Species 0.000 abstract 1
- 244000269722 Thea sinensis Species 0.000 abstract 1
- 235000012000 cholesterol Nutrition 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- 230000037303 wrinkles Effects 0.000 abstract 1
- 230000006870 function Effects 0.000 description 20
- 241000125175 Angelica Species 0.000 description 17
- 210000004185 liver Anatomy 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 9
- 230000036407 pain Effects 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 230000009471 action Effects 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 230000000144 pharmacologic effect Effects 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 230000000242 pagocytic effect Effects 0.000 description 5
- 239000000341 volatile oil Substances 0.000 description 5
- 230000000202 analgesic effect Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000005022 packaging material Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000002279 cholagogic effect Effects 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- BGEBZHIAGXMEMV-UHFFFAOYSA-N 5-methoxypsoralen Chemical compound O1C(=O)C=CC2=C1C=C1OC=CC1=C2OC BGEBZHIAGXMEMV-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- KGEKLUUHTZCSIP-HOSYDEDBSA-N [(1s,4s,6r)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Chemical compound C1C[C@]2(C)[C@H](OC(=O)C)C[C@H]1C2(C)C KGEKLUUHTZCSIP-HOSYDEDBSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical compound C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241001105170 Angelica anomala Species 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- DBMJZOMNXBSRED-UHFFFAOYSA-N Bergamottin Natural products O1C(=O)C=CC2=C1C=C1OC=CC1=C2OCC=C(C)CCC=C(C)C DBMJZOMNXBSRED-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 240000003759 Erodium cicutarium Species 0.000 description 1
- 235000009967 Erodium cicutarium Nutrition 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010027146 Melanoderma Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- BMLZFLQMBMYVHG-UHFFFAOYSA-N Phellopterin Chemical compound O1C(=O)C=CC2=C1C(OCC=C(C)C)=C1OC=CC1=C2OC BMLZFLQMBMYVHG-UHFFFAOYSA-N 0.000 description 1
- XXARIFJTXNCWNT-UHFFFAOYSA-N Phellopterin Natural products COc1c2C=CC(=O)Oc2c(OC=CC(C)C)c3occc13 XXARIFJTXNCWNT-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
- 244000226566 Psoralea corylifolia Species 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 240000004980 Rheum officinale Species 0.000 description 1
- 235000008081 Rheum officinale Nutrition 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- UZXMLGUMBQQVME-UHFFFAOYSA-N Swietenocoumarin B Natural products O1C(=O)C=CC2=C1C(CC=C(C)C)=C1OC=CC1=C2OC UZXMLGUMBQQVME-UHFFFAOYSA-N 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000000703 anti-shock Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 229960002045 bergapten Drugs 0.000 description 1
- KGZDKFWCIPZMRK-UHFFFAOYSA-N bergapten Natural products COC1C2=C(Cc3ccoc13)C=CC(=O)O2 KGZDKFWCIPZMRK-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 229940115397 bornyl acetate Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 206010009869 cold urticaria Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 230000010437 erythropoiesis Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 150000002240 furans Chemical class 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- -1 lactones glucoside Chemical class 0.000 description 1
- 230000004132 lipogenesis Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000004493 neutrocyte Anatomy 0.000 description 1
- 239000000346 nonvolatile oil Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 208000017983 photosensitivity disease Diseases 0.000 description 1
- 231100000434 photosensitization Toxicity 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001185 psoriatic effect Effects 0.000 description 1
- 230000009325 pulmonary function Effects 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种美容调节酒。包括下列原料:羌活、防风、当归、赤芍、姜黄、黄芪、白芷、白蔹、决明子、桃花、炙甘草和白酒。本发明美容调节酒色泽为琥珀色,透明,口感醇和,药味淡。服用方法;每日一至两次,饭前服用。每次30-50毫升。保健功能在于:白酒本身可以促进消化,增加食欲,加速血液循环,预防心血管疾病,改善新陈代谢,使人精力旺盛;在酒中加入黄芪,当归调补气血外,羌活,白芷,防风等温经散寒,适量饮用可增加高密度脂蛋白含量,减少动脉内胆固醇的沉积,预防心血管病;适量饮用使人的皮肤色泽红润,弹性增加,达到美颜,祛斑,抗皱,养生保健作用。
Description
技术领域
本发明属于保健类饮料技术领域,具体涉及一种保健酒。
背景技术
有人说,女人是美的信徒,为了美,有人瘦身,有人丰胸;为了美、有人整容,有人洗肠。可以说:爱美是女人的天性,只要有助于美的方式,女人都乐于打听,乐于接受。美又是一道风景,肌肤娇嫩,白里透红,看了十分养眼,心情格外明亮。然而,爱美也是一件苦差使。比如减肥,你得饱受饥肠漉漉的痛苦,即使是最诱人的食物也要加以控制,否则就会前功尽弃。比如洗肠,你得忍受难言的困扰,才能清除体内宿便,换来美丽的容颜。又如整容,你得冒着手术失败的风险,才能打造出理想的美人。这些美的方式,虽然可使女人“改头换面”,但对女人来说却是一个非常艰苦的历程。而且这种美无法超越自然、纯净、内在的美。那么,女人想美,除了运用各种化妆品与物理方法外,还有什么可以使自已美得自然、纯净、美的怡人呢?
在我国伟大的中医药宝库中,记载着许多中草药与酒结合配制的美酒。她为营造女人的美丽增添了广宽天地。汉书中称“酒为百药之长”,酒味辛、性温。温者能祛寒和中,辛者能发散、疏导。所以酒能疏通经脉,行气和血。酒作为容剂,中药的各种有效成分都易溶于其中,药借酒力,酒助药势而充分发挥其效力,提高美容效果。古往今来,肤如凝脂,冰清玉洁的佳丽,都是无数人向往,梦寐以求的。传统中医认为,一个人的容颜色泽,主要取决于人体内部阴阳平衡、气血盛衰。因此,调理人体阴阳、气血和内部脏腑功能就能青春永驻,使自已肌肤美白,容光焕发。
发明内容
为了借酒之性提升药之性,使调理人体阴阳、气血、脏腑功能达到更好的发挥,起到美容效果,本发明提供一种美容调节酒。
具体的技术方案如下:
一种美容调节酒包括下列重量份的原料:
羌活50-60 g 、防风50-60g、当归50-60 g、赤芍50-60 g、姜黄50-60 g、黄芪50-60g、 决明子50-60 g、白芷50-60 g、白蔹50-60 g、炙甘草30-40g、桃花30-40g 、白酒10Kg;
所述羌活、防风、当归、赤芍、姜黄、黄芪、白芷、白蔹、决明子、桃花、炙甘草为饮片或粗粉。
所述白酒为52℃粮食白酒10Kg。
—种美容调节酒的制备方法包括以下操作步骤:
A、将上述配方中的羌活、防风、当归、赤芍、 姜黄、黄芪、白芷、白蔹、决明子、桃花、炙甘草放入5 Kg白酒中浸渍15天得到第一次浸渍液;
B、取第一次浸渍液以每分钟1/1000(V/V)流速渗漉,收集第一次漉液,第一次漉液的量为全量的1/3,在剩余的2/3第一次浸渍液中加入2.5 Kg白酒浸渍10天,得到第二次浸渍渗液;
C、取第二次浸渍液以每分钟1/1000(V/V)流速渗漉,收集第二次漉液,第二次漉液的量为全量的1/3,在剩余的2/3第二次浸渍液中加入2.5Kg白酒浸渍10天,得到第三次浸渍渗液;
D、合并第一次漉液、第二次漉液和第三次浸渍渗液,静置3天,过滤得到美容调节酒。
本发明美容调节酒中各成分的作用如下:
羌活:味辛、苦、性温。入膀胱、肾经。主要成份,含挥发性成份如α-蒎烯、β-蒎烯、乙酸龙脑酯等数十种挥发性成份及有机酸。还含有果糖以及赖氨酸、天冬氨酸等十七种氨基酸。功能:1、解热、镇痛作用。羌活挥发油灌胃或腹腔注射,能使致热性大鼠体温明显降低,具有显著的解热和调和营卫功能。2、羌活对心律失常有明显的对抗作用,并有扩张冠状动脉、增加营养性血流量,从而改善心肌缺血。3、羌活煎剂有抗休克作用,动物实验表明:姜活挥发油还有抗炎和抗过敏作用。
防风:味辛、甘、性温。入膀胱、肺、肝、脾经。功能:发表、祛风、性温、解痉止痛。主要成份:含挥发油如蒎烯、乙醛、乙醇等。亦含香豆素类如补骨脂索、香柑内酯、珊瑚菜素等,并含色原酮类、多糖类、胡萝卜甙、苷露醇等。药理作用:1、解热作用2、镇痛镇静作用3、抗菌抗炎作用4、对免疫功能作用主要能显著提高小鼠腹腔巨噬细胞吞噬率与吞噬指数。临床运用:治疗风寒感冒、面神经麻痹、寒冷性荨麻疹等症。
当归:味甘、辛、性温。入肝、心、脾。功能和血、调经止痛,润燥滑肠。主要成份:当归含多种挥发油和非挥发油,还含有蔗糖、果糖、维生素A,维生素B12、维生素E等17种氨基酸以及钠、钾、钙、镁等20余种无机元素。药理作用:1、当归是重要的心血管营养性药物,能增加冠脉血流量降低心肌 耗氧量并能对抗心律失常。2、对血液系统的作用,降低血脂及对动脉粥样硬化的影响。当归及其成份阿魏酸有抗氧化和清除自由基作用、对血管壁来说有很好保护作用,且有降低血小板聚集和抗血栓作用。3、临床及实验研究表明,当归有显著促进血红蛋及红细胞生成。4、抗氧化和清除自由基的作用。且有抗炎、镇痛及抗损伤作用。5、对免疫系统有促进非特异性免疫功能作用,可显著增强动物巨噬细胞的吞噬功能。当归多糖能明显促进机体免疫功能。6、对子宫有双向调节作用。并有护肝、美容、抗菌、抗辐射等多项保健功能。
黄芪:味甘、性微温,入肺、脾经,生用:益卫固表,利水消肿,托毒生肌。药理作用:1、黄芪是重要的强心、抗疲劳、抗衰老补中益气之要药。对心血管及冠状动脉有扩张作用,因而可降低血压。2、对中枢神经系统有镇静和镇痛作用。3、对应激反应方面表现在抗疲劳、抗缺氧、抗衰老等都很显著。黄芪的长期作用对预防老年性动脉硬化,改善衰老的肺功能有一定帮助,黄芪尚有明显的抗辐射作用,促进造血功能并提高琥珀酸脱氢酶的活性。4、对免疫系统能增强网状内皮系统吞噬能力。能显著增强和调节机体免疫能力。5、实验证明:黄芪含有多种活性物质增强细胞生理代谢,延缓细胞自然衰老,约能延长细胞寿命1/3左右。另外,黄芪多糖具有双身调节血糖,并能降低血液粘稠度,促进受损肝细胞的修复,抑制细胞过氧化,促进中性粒细胞生成等多项保健功能。
决明子:味苦,甘,性凉,入肝,肾经。功能:清肝,明目,利水,通便。药理作用:决明子有良好利胆通便排毒养颜作用,同时也有一定的抗病原微生物和调节免疫功能,是一种常用的保健美容良药。
赤芍:味酸,苦、性凉。入肝脾。功能:清热、凉血、行瘀、消肿、止痛。主治瘀滞经闭、疝癥积聚、腹痛、血痢、肠风下血、目赤、痛肿等。主要成份:含芍药甙、芍药内脂甙、氧化芍药甙、芍药精及挥发油等。药理作用:1、芍药甙具有镇静、镇痛和抗惊厥作用。2、对心血管作用赤芍有直接扩张冠状动脉、增加营养血流量,改善心肺功能作用。3、赤芍有调节血液凝固和纤维蛋白溶解系统的作用。研究表明:赤芍精对高粘滞血冠心病患者有改变血液流变性的作用。4、抗炎和免疫系统的作用。可使状内皮系统吞噬指数显著提高。5、芍药甙具有较好的解痉作用。
白芷:味辛、性凉。入肺、脾、胃经。功能:祛风、燥湿、消肿、止痛。主要成份:白芷全草含挥发油,川白芷鉴定出69种化学成份。如3-亚甲荃环已烯,十六烷酸等。药理作用:1、抗菌作用2、对脂肪代谢的作用,与肾上腺素ACTH共存并对这些激素起活化作用,从而间接发挥促进脂肪分解和抑制脂肪合成作用。3、白芷中线呋喃豆香素具有光敏作用,因而增强银屑病的疗效。4、有人用白芷、桃花浸酒治疗面色晦暗、黑斑、黑褐斑、妊娠斑患者20例效果显著。一般30-60天见效。
白蔹:味苦、甘、辛、性凉。入心肝、脾经。功能:清热解毒、散结止痛。蔹疮生肌。常应用于:痛肿,疔疮,瘰厉,烫伤,血痢,肠风,痔漏等。1、治疗化脓性皮肤病。有报导称:用白蔹90g去皮研细末,以沸水搅拌成团后,加75-95%乙醇调成糊状外敷患处,每日一次,治疗疖、痈、蜂窝织炎各种炎性肿块等用药后疼痛减轻,炎症很快吸收或局限。一般经治疗2-3天可愈,在炎症初期效果更佳。2、治疗手足皱裂,白蔹、白芷各30g大黄50g焙黄研粉,冰片3g研极细粉和匀过筛加蜂蜜调成稠糊状,将患处洗净擦干后涂敷药膏,每日3-5次,治疗55例、痊愈44例,好转8例,无效3例,轻者3-5天见效,重者7-10天治愈。白蔹苦泄,能清湿热而通壅滞,面部疮毒、斑疹皆属热痰瘀结或湿火结于肝肾脉络,而白芷辛温燥湿两药相需而用,可增加苦泄、宣通之作用。
本发明以黄芪、当归为君,传统中医认为:一个人容颜美丑与人体内部阴阳平衡、气血充盈调和密切相关,黄芪泄邪火,益元气,实皮毛为补气益血,达到抗衰老的目的。气血足、人才美。当归补血养颜,调经止痛,润肠通便,当归被中医誉为“妇科之圣药”。 当归活血、补血、血脉充盈、旺盛是最有效的养颜剂。因为它内可养脏腑,外可养皮毛。而防风、羌活解毒除湿为臣。白芷、白蔹,桃花美肤增白为佐,赤芍、姜黄、决明子、炙甘草清肝利胆排毒为使,共同辅佐黄芪、当归补气养血、和肝利胆、排毒美颜。它的保健功能主要体现在以下方面;1现代医学研究证明适量饮酒对人体有一定的益处。酒本身就是一种很好的营养剂,尤其是实粮食原浆酒,适量饮酒不仅可以促进消化,增加食欲。还能够加速血液循环,预防心血管疾病,改善新陈代谢,使人精力旺盛。并有助于身心健康和延年益寿。2在酒中加入黄芪,当归调补气血外,还有羌活,白芷,防风等温经散寒的成份,适量饮用可增加高密度脂蛋白含量,减少动脉内胆固醇的沉积,对防止心血管病有帮助。同时适量饮用可通经活络,加速血液循环,对关节伸屈不利,风湿痺痛,神经麻木以及中老年肝肾俩虚所致的筋骨疼痛等有保健作用。3常期适量饮用美容调节酒可调理脏腑,气血,阴阳之偏差,促进人体新陈代谢,使人的皮肤色泽红润,弹性增加,达到美颜,祛斑,抗皱,养生保健作用。
本发明美容调节酒色泽为琥珀色,透明,口感醇和。药味淡。
服用方法;每日一至两次,饭前服用。每次30-50毫升。
具体实施方式
下面结合实施例,对本发明作进一步地描述。
实施例1:
一种美容调节酒包括下列重量份的原料:
羌活60 g 、防风60g、当归60 g、赤芍60 g、姜黄60 g、黄芪60g、决明子60 g、白芷60 g、白蔹60 g、炙甘草40g、桃花40g 、52度粮食白酒10Kg。
上述羌活、防风、当归、赤芍、姜黄、黄芪、白芷、白蔹、决明子、桃花、炙甘草为饮片。
—种美容调节酒的制备操作步骤如下:
A、将上述配方中的羌活、防风、当归、赤芍、 姜黄、黄芪、白芷、白蔹、决明子、桃花、炙甘草放入5 Kg白酒中浸渍15天得到第一次浸渍液;
B、取第一次浸渍液以每分钟1/1000(V/V)流速渗漉,收集第一次漉液,第一次漉液的量为全量的1/3,在剩余的2/3第一次浸渍液中加入2.5 Kg白酒浸渍10天,得到第二次浸渍渗液;
C、取第二次浸渍液以每分钟1/1000(V/V)流速渗漉,收集第二次漉液,第二次漉液的量为全量的1/3,在剩余的2/3第二次浸渍液中加入2.5Kg白酒浸渍10天,得到第三次浸渍渗液;
D、合并第一次漉液、第二次漉液和第三次浸渍渗液,静置3天,过滤得到美容调节酒。
实施例2:
一种美容调节酒包括下列重量份的原料:
羌活50 g 、防风50g、当归50 g、赤芍50 g、姜黄50 g、黄芪50g、决明子50 g、白芷50 g、白蔹50 g、炙甘草30g、桃花30g 、52度粮食白酒10Kg。
上述羌活、防风、当归、赤芍、姜黄、黄芪、白芷、白蔹、决明子、桃花、炙甘草为粗粉。
美容调节酒的制备方法同实施例1。
实施例3:
一种美容调节酒包括下列重量份的原料:
羌活55 g 、防风55 g、当归55 g、赤芍55 g、姜黄55 g、黄芪55 g、决明子55 g、白芷55 g、白蔹55 g、炙甘草35 g、桃花35 g 、52度粮食白酒10Kg。
上述羌活、防风、当归、赤芍、姜黄、黄芪、白芷、白蔹、决明子、桃花、炙甘草为饮片。
美容调节酒的制备方法同实施例1。
Claims (3)
1.一种美容调节酒,其特征在于原料及重量为:
羌活50-60g、防风50-60g、当归50-60g、赤芍50-60g、姜黄50-60g、黄芪50-60g、决明子50-60g、白芷50-60g、白蔹50-60g、炙甘草30-40g、桃花30-40g、白酒10Kg;
所述羌活、防风、当归、赤芍、姜黄、黄芪、白芷、白蔹、决明子、桃花、炙甘草为饮片或粗粉。
2.根据权利要求1所述的一种美容调节酒,其特征在于:所述白酒为52℃粮食白酒10Kg。
3.如权利要求1所述的一种美容调节酒的制备方法,其特征在于包括以下操作步骤:
A、将羌活50-60g、防风50-60g、当归50-60g、赤芍50-60g、姜黄50-60g、黄芪50-60g、白芷50-60g、白蔹50-60g、决明子50-60g、桃花30-40g、炙甘草30-40g放入5Kg白酒中浸渍15天得到第一次浸渍液;
B、取第一次浸渍液以每分钟1/1000V/V流速渗漉,收集第一次漉液,第一次漉液的量为全量的1/3,在剩余的2/3第一次浸渍液中加入2.5Kg白酒浸渍10天,得到第二次浸渍渗液;
C、取第二次浸渍液以每分钟1/1000V/V流速渗漉,收集第二次漉液,第二次漉液的量为全量的1/3,在剩余的2/3第二次浸渍液中加入2.5Kg白酒浸渍10天,得到第三次浸渍渗液;
D、合并第一次漉液、第二次漉液和第三次浸渍渗液,静置3天,过滤得到美容调节酒。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011100094185A CN102161960B (zh) | 2011-01-17 | 2011-01-17 | 一种美容调节酒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011100094185A CN102161960B (zh) | 2011-01-17 | 2011-01-17 | 一种美容调节酒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102161960A CN102161960A (zh) | 2011-08-24 |
CN102161960B true CN102161960B (zh) | 2012-05-30 |
Family
ID=44463414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011100094185A Expired - Fee Related CN102161960B (zh) | 2011-01-17 | 2011-01-17 | 一种美容调节酒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102161960B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105106615A (zh) * | 2015-08-28 | 2015-12-02 | 李嘉 | 一种祛斑美颜药酒 |
CN107151601A (zh) * | 2017-07-06 | 2017-09-12 | 长沙爱扬医药科技有限公司 | 利用白蔹根茎制备保健酒的方法 |
CN107299016A (zh) * | 2017-07-06 | 2017-10-27 | 长沙湘资生物科技有限公司 | 富含小肽的保健酒饮料产品 |
CN113559220A (zh) * | 2021-08-24 | 2021-10-29 | 孙应政 | 一种保健美容养生药酒的制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1176800A (zh) * | 1996-09-13 | 1998-03-25 | 唐山钢铁集团有限责任公司 | 祛风壮骨酒的制备方法 |
CN1229658A (zh) * | 1998-03-24 | 1999-09-29 | 刘月江 | 复方三痹痛风药酒 |
-
2011
- 2011-01-17 CN CN2011100094185A patent/CN102161960B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1176800A (zh) * | 1996-09-13 | 1998-03-25 | 唐山钢铁集团有限责任公司 | 祛风壮骨酒的制备方法 |
CN1229658A (zh) * | 1998-03-24 | 1999-09-29 | 刘月江 | 复方三痹痛风药酒 |
Non-Patent Citations (1)
Title |
---|
邓中甲 等.蠲痹汤.《方剂学》.上海科学技术出版社,2008,第268页. * |
Also Published As
Publication number | Publication date |
---|---|
CN102161960A (zh) | 2011-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104509619A (zh) | 一种中药减肥保健茶及其制备方法 | |
CN102657278A (zh) | 一种芦笋养生茶 | |
CN104825801A (zh) | 一种预防和治疗心脑血管疾病的中药制剂 | |
CN106387096A (zh) | 一种保健芝麻油及其制备方法 | |
CN104740541A (zh) | 一种保肝解毒恢复肝功能的保健中药粉 | |
CN104758806A (zh) | 一种治疗冠心病的煎膏剂及其制备方法 | |
CN102161960B (zh) | 一种美容调节酒 | |
CN103749824B (zh) | 一种绞股蓝降糖降压保健茶及其制备方法 | |
CN101804110B (zh) | 一种抗血栓和降血脂的中药制剂 | |
CN104173773A (zh) | 偏头痛祛风活血制剂及制备方法 | |
CN104173517B (zh) | 治疗原发性三叉神经痛的中药制剂及制备方法 | |
CN106421325A (zh) | 软化肝胆结石的组合物 | |
CN104474298A (zh) | 治疗白癜风的中药 | |
CN103656226A (zh) | 一种治疗干燥综合征复方药 | |
CN102362982A (zh) | 一种用于中风先兆预防血栓的中药制剂及其制备方法 | |
CN114748583A (zh) | 一种滋补养生的中药药酒 | |
CN105456924A (zh) | 含有艾叶的具有活血化瘀功能的中药制剂及其制备方法 | |
CN105311375A (zh) | 一种降低血脂的组合物 | |
CN104825864A (zh) | 对放疗具有增效作用的保健药膳及制备方法 | |
CN104623532A (zh) | 一种治疗脑胶质瘤的中药组合物及其制备方法 | |
CN103028063B (zh) | 一种治疗肾病的中药组合物 | |
CN101890069A (zh) | 预防和治疗痛风病的药物及其制备工艺 | |
CN1958036A (zh) | 一种绞股蓝养颜酒 | |
CN101057915A (zh) | 养肾痛风胶囊 | |
CN105853626A (zh) | 一种治疗脂肪肝、高血脂的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120530 Termination date: 20210117 |
|
CF01 | Termination of patent right due to non-payment of annual fee |